Drug Profile
Bulaquine
Alternative Names: Aablaquin; Bulaquin; CDRI 80/53; Ebulaquin; Elubaquin; ElubaquineLatest Information Update: 10 Aug 2000
Price :
$50
*
At a glance
- Originator Central Drug Research Institute
- Developer Central Drug Research Institute; Piramal Enterprises
- Class Antiparasitics; Quinolines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Malaria
Most Recent Events
- 10 Aug 2000 Launched for Malaria in India (Unknown route)
- 25 Apr 2000 Registered for Malaria in India (Unknown route)
- 31 Dec 1999 Bulaquine licensed to Nicholas Piramal in India